demyelination
Showing 1 - 25 of 402
Longitudinal Cortical Demyelination in Multiple Sclerosis and
Recruiting
- Multiple Sclerosis
- +2 more
-
New York, New YorkMount Sinai Hospital
Aug 8, 2023
Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
Not yet recruiting
- CIDP
- IVIg
-
Nashville, TennesseeVanderbilt University
Nov 4, 2022
Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)
Recruiting
- Multiple Sclerosis
- Clinically Isolated Syndrome of Demyelination
- Tysabri Injectable Product
- Placebo
-
London, United KingdomRoyal London Hospital
Jan 25, 2023
Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)
Recruiting
- Multiple Sclerosis
- 18F-florbetaben PET/CT
-
Pavia, PV, ItalyICS Maugeri SpA SB IRCCS
Mar 23, 2023
Gray Matter Demyelination in Primary Progressive MS at 7T
Recruiting
- Primary Progressive Multiple Sclerosis
-
Hvidovre, DenmarkDanish Research Centre for Magnetic Resonance
Jun 5, 2022
Disability, MRI Lesions and Thickness of Retinal Fibers:
Completed
- Multiple Sclerosis
- +4 more
- Cerebral MRI and Optical Coherence Tomography
-
Paris, FranceFondation Ophtalmologique A. de Rothschild
Apr 21, 2022
Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine
Not yet recruiting
- Demyelinating Diseases
- +4 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Oct 3, 2023
Combined Central and Peripheral Demyelination
Not yet recruiting
- Combined Central and Peripheral Demyelination Disease
- (no location specified)
Dec 11, 2020
Multiple Sclerosis Trial in Boston (F-18 3F4AP)
Recruiting
- Multiple Sclerosis
- F-18 3F4AP
-
Boston, MassachusettsMassachusetts General Hospital
May 10, 2021
Optic Neuritis, Optic; Neuritis, With Demyelination Trial in Paris (ACT-01 IV administration, Placebo IV administration)
Recruiting
- Optic Neuritis
- Optic; Neuritis, With Demyelination
- ACT-01 IV administration
- Placebo IV administration
-
Paris, FranceCIC Neurosciences - La Pitié Salpêtrière
Feb 23, 2022
Multiple Sclerosis Trial in New Haven ([18F]Florbetapir PET imaging)
Completed
- Multiple Sclerosis
- [18F]Florbetapir PET imaging
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Aug 26, 2021
Brain Injuries, Traumatic, Demyelinating Disorder, Alzheimer Trial in Boston (F18-3F4AP)
Recruiting
- Brain Injuries, Traumatic
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 23, 2021
A Registered Cohort Study of Inflammatory Demyelination Disease
Recruiting
- Demyelinating Autoimmune Diseases, CNS
-
Fuzhou, Fujian, ChinaDepartment of Neurology,First Affiliated Hospital of Fujian Medi
Nov 11, 2020
Relapsing Remitting Multiple Sclerosis, Optic Neuropathy, Optic; Neuritis, With Demyelination Trial in Australia, Canada, United
Terminated
- Relapsing Remitting Multiple Sclerosis
- +2 more
- CNM-Au8
- Placebo
-
Dallas, Texas
- +6 more
Aug 10, 2022
Hyponatremia, Osmotic Demyelination Syndrome Trial in Bangkok (3%NaCl)
Unknown status
- Hyponatremia
- Osmotic Demyelination Syndrome
- 3%NaCl
-
Bangkok, ThailandRajavithi Hospital
Feb 24, 2021
Multiple Sclerosis Trial in Ladera Ranch (Entire-body PET-CT scans, Amyvid radiopharmaceutical)
Recruiting
- Multiple Sclerosis
- Entire-body PET-CT scans
- Amyvid radiopharmaceutical
-
Ladera Ranch, CaliforniaBrain Health Alliance
Mar 31, 2022
Lysosomal Storage Diseases, Metachromatic Leukodystrophy Trial in Milan (OTL-200)
Recruiting
- Lysosomal Storage Diseases
- Metachromatic Leukodystrophy
- OTL-200
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 16, 2022
Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Athens, GreeceLocal Institution - 0001
Oct 26, 2022
Nursing Caries Trial (Occulus quest 2 virtual reality glasses)
Not yet recruiting
- Nursing Caries
- Occulus quest 2 virtual reality glasses
- (no location specified)
Oct 6, 2023
Central and Peripheral Nervous System Changes as Markers of
Completed
- Multiple Sclerosis
- +7 more
-
Sønderborg, Jylland, DenmarkDepartment of Neurology (Skleroseklinikken), Sygehus Sønderjylla
Oct 13, 2021
VIsual Pathways Model in Neuro-inflammatory Disorders
Not yet recruiting
- Optic Neuritis
- Clinical examen
- (no location specified)
Aug 2, 2022
Hyponatremia Trial (DDAVP, Standard hyponatremia treatment)
Not yet recruiting
- Hyponatremia
- DDAVP
- Standard hyponatremia treatment
- (no location specified)
Aug 28, 2023
CNS Inflammatory Demyelinating Diseases
Not yet recruiting
- Multiple Sclerosis
- +4 more
- Intravenous steroid
- (no location specified)
Nov 29, 2021
Vestibular Schwannoma Trial in Rochester (Omega-3, Placebo)
Recruiting
- Vestibular Schwannoma
- Omega-3
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 11, 2022
Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,
Recruiting
- Adrenoleukodystrophy
- +3 more
- Blood sample collection
-
Le Kremlin-Bicêtre, France
- +1 more
Oct 10, 2022